Is Ozempic (Semaglutide) Right For Me? episode artwork

EPISODE · Apr 25, 2022 · 40 MIN

Is Ozempic (Semaglutide) Right For Me?

from Eat Move Think · host Ghost Bureau Content Services

Health Canada recently approved a new weight loss drug, semaglutide, also known as "Ozempic" or "Wegovy." Experts refer to it as a "game changer" for its ability to curtail appetite and spur weight loss. In this episode, Medcan's director of weight management, Dr. David Macklin, a co-author of Canada's national guidelines for obesity treatment, provides host Shaun Francis with a semaglutide explainer. "We're in a super exciting stage in my field of medicine," Dr. Macklin says. Check out episode highlights and links on our webpage.

Episode metadata supplied by the publisher feed · Published Apr 25, 2022

Embed this episode

NOW PLAYING

Is Ozempic (Semaglutide) Right For Me?

0:00 40:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Eat Move Think?

This episode is 40 minutes long.

When was this Eat Move Think episode published?

This episode was published on April 25, 2022.

Can I download this Eat Move Think episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!